凯赛生物拟推2025年员工持股计划

Core Viewpoint - 凯赛生物 has announced a draft employee stock ownership plan (ESOP) for 2025, aimed at enhancing talent retention and attracting skilled personnel [1] Group 1: Employee Stock Ownership Plan Details - The ESOP will include up to 155 participants, excluding reserved shares, comprising directors (excluding independent directors), senior management, middle management, and key technical (business) personnel [1] - The total number of shares to be held under the ESOP will not exceed 1.3 million shares, representing approximately 0.18% of the company's total share capital at the time of the announcement [1] - A reserve of 150,000 shares will be set aside, accounting for 11.54% of the total shares in the ESOP [1] Group 2: Stock Purchase Price - The purchase price for the shares from the company's repurchase account will be set at 25.53 yuan per share, including reserved shares [1]